Health Disparities and World Health Day

There are important health disparities right here in southeastern Wisconsin.

Symjepi: A new option for injectable epinephrine

The FDA has approved Symjepi, a new device for injectable epinephrine. Patients now have an additional option when choosing an epinephrine injector with their allergist.

Wixela: Generic version of Advair now approved

The FDA has approved Wixela, a generic form of the Advair inhaler. With this generic, we will hopefully see some of the price relief we need in the treatment of asthma!

FDA approves Primatene Mist

The Food and Drug Administration approved Primatene Mist for over-the-counter status. Allergists across the country are voicing their concerns about this decision.

FDA alerts patients with EpiPens

The Food and Drug Administration alerts patients and providers that the labels on certain auto injectors may prevent easily removing the device from its carrier tube.

Publication: Shared decision making for the allergist

Dr. Steven was the second author on a publication in the October 2018 Annals of Allergy, Asthma & Immunology for his contributions to the new shared decision making tool.

Dupixent: New treatment for asthma

The FDA announced the approval of Dupixent (dupilumab), a new treatment for asthma. Unlike steroids, Dupixent targets just one component of asthmatic inflammation.

Peanut Allergy Alert: Ice Cream Recall

Kemps is recalling Sweet Me Creamery Brookie Dough ice cream as certain lots may contain an undeclared peanut allergen. No other Sweet Me products have been affected.

WANT TO READ EVEN MORE NEWS ARTICLES?

Visit the Allergy, Asthma & Sinus Center news archive to see all of our news items from the last two years.